ICU Map
ConsensusCurrent

ETA/BTA/SfE/WEDS 2026 — Management of endocrine emergencies: joint consensus statement for management of myxoedema coma

European Thyroid Association / British Thyroid Association / Society for Endocrinology / Welsh Endocrine and Diabetes Society, 2026

Treat suspected myxoedema coma immediately in a high-dependency or intensive-care setting with supportive resuscitation, empiric stress-dose glucocorticoid, cautious IV levothyroxine replacement, treatment of precipitants, passive warming, and close cardiovascular, respiratory, metabolic and thyroid-function monitoring; liothyronine is reserved for selected cases because of cardiac risk.

Expert opinionLow certainty
View source guideline